Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.

Ringheim GE, Lee L, Laws-Ricker L, Delohery T, Liu L, Zhang D, Colletti N, Soos TJ, Schroeder K, Fanelli B, Tian N, Arendt CW, Iglesias-Bregna D, Petty M, Ji Z, Qian G, Gaur R, Weinstock D, Cavallo J, Telsinskas J, McMonagle-Strucko K.

Front Neurol. 2013 Oct 30;4:169. doi: 10.3389/fneur.2013.00169. eCollection 2013.

2.

Opposing effects of PKCtheta and WASp on symmetry breaking and relocation of the immunological synapse.

Sims TN, Soos TJ, Xenias HS, Dubin-Thaler B, Hofman JM, Waite JC, Cameron TO, Thomas VK, Varma R, Wiggins CH, Sheetz MP, Littman DR, Dustin ML.

Cell. 2007 May 18;129(4):773-85.

3.

CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseases.

Soos TJ, Meijer L, Nelson PJ.

Drug News Perspect. 2006 Jul-Aug;19(6):325-8. Review.

PMID:
16971968
4.

Collapsing glomerulopathy.

Albaqumi M, Soos TJ, Barisoni L, Nelson PJ.

J Am Soc Nephrol. 2006 Oct;17(10):2854-63. Epub 2006 Aug 16. Review.

5.

CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney.

Soos TJ, Sims TN, Barisoni L, Lin K, Littman DR, Dustin ML, Nelson PJ.

Kidney Int. 2006 Aug;70(3):591-6. Epub 2006 Jun 7.

6.

PKC-theta knockout mice are protected from fat-induced insulin resistance.

Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, Kim DW, Liu ZX, Soos TJ, Cline GW, O'Brien WR, Littman DR, Shulman GI.

J Clin Invest. 2004 Sep;114(6):823-7.

7.

Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101).

Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, Littman DR, Birnbaum MJ, Polakiewicz RD.

J Biol Chem. 2004 Oct 29;279(44):45304-7. Epub 2004 Sep 10.

8.

Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses.

Marsland BJ, Soos TJ, Sp├Ąth G, Littman DR, Kopf M.

J Exp Med. 2004 Jul 19;200(2):181-9.

9.

Protein kinase C-theta;: signaling from the center of the T-cell synapse.

Arendt CW, Albrecht B, Soos TJ, Littman DR.

Curr Opin Immunol. 2002 Jun;14(3):323-30. Review.

PMID:
11973130
10.

Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation.

Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME, Koff A, Adams JM.

Mol Cell Biol. 2000 Jul;20(13):4745-53.

11.

Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.

Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2247-51.

12.

The absence of p27Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa->luteal transition.

Tong W, Kiyokawa H, Soos TJ, Park MS, Soares VC, Manova K, Pollard JW, Koff A.

Cell Growth Differ. 1998 Sep;9(9):787-94.

13.

Regulation of the cell cycle by CDK inhibitors.

Soos TJ, Park M, Kiyokawa H, Koff A.

Results Probl Cell Differ. 1998;22:111-31. Review. No abstract available.

PMID:
9670321
14.

Formation of p27-CDK complexes during the human mitotic cell cycle.

Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A.

Cell Growth Differ. 1996 Feb;7(2):135-46.

Supplemental Content

Support Center